InvestSMART

TrivarX Ltd (ASX: TRI) - Announcements

- Current share price for TRI : $0.011

ASX company news and announcements for TrivarX Ltd (TRI) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All TrivarX Ltd (TRI) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than TrivarX Ltd (TRI), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for TrivarX Ltd (TRI)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$13 Notification of cessation of securities - TRI 9 Dec 2025 12:54PM $0.020 $0.011 fallen by 45%
$13 Resignation of Director - John Mathias 5 Dec 2025 11:15AM $0.023 $0.011 fallen by 52.17%
$13 Change of Director's Interest Notice - Tony Keating 2 Dec 2025 6:20PM $0.021 $0.011 fallen by 47.62%
$13 Change of Director's Interest Notice - John Mathias 2 Dec 2025 6:19PM $0.021 $0.011 fallen by 47.62%
$13 Change of Director's Interest Notice - David Trimboli 2 Dec 2025 6:18PM $0.021 $0.011 fallen by 47.62%
$13 Change of Director's Interest Notice - Chris Ntoumenopoulos 2 Dec 2025 6:17PM $0.021 $0.011 fallen by 47.62%
$13 Cleansing Notice 2 Dec 2025 6:16PM $0.021 $0.011 fallen by 47.62%
$13 Notification regarding unquoted securities - TRI 2 Dec 2025 6:14PM $0.021 $0.011 fallen by 47.62%
$13 Application for quotation of securities - TRI 2 Dec 2025 6:10PM $0.021 $0.011 fallen by 47.62%
$13 Results of Annual General Meeting 21 Nov 2025 12:24PM $0.022 $0.011 fallen by 50%
$13 Update - Proposed issue of securities - TRI 12 Nov 2025 10:58AM $0.022 $0.011 fallen by 50%
$13 Update - Proposed issue of securities - TRI 12 Nov 2025 10:54AM $0.022 $0.011 fallen by 50%
$13 Notice of General Meeting & Proxy Form & Access Letter 12 Nov 2025 10:33AM $0.022 $0.011 fallen by 50%
$13 TRI Exercises Option to Advance Acquisition of Stabl-Im 5 Nov 2025 8:48AM $0.028 $0.011 fallen by 60.71%
$13 September 2025 Quarterly Activities Report and Appendix 4C 31 Oct 2025 8:37AM $0.022 $0.011 fallen by 50%
$13 Change in substantial holding - FIL Limited and associates 30 Oct 2025 9:12AM $0.022 $0.011 fallen by 50%
$13 Change in substantial holding 29 Oct 2025 5:29PM $0.022 $0.011 fallen by 50%
$13 Notification regarding unquoted securities - TRI 29 Oct 2025 10:46AM $0.025 $0.011 fallen by 56%
$13 Cleansing Notice 27 Oct 2025 9:17AM $0.027 $0.011 fallen by 59.26%
$13 Application for quotation of securities - TRI 27 Oct 2025 9:17AM $0.027 $0.011 fallen by 59.26%
$13 Application for quotation of securities - TRI 27 Oct 2025 9:13AM $0.027 $0.011 fallen by 59.26%
$13 Proposed issue of securities - TRI 22 Oct 2025 1:09PM $0.028 $0.011 fallen by 60.71%
$13 Letter to Shareholders & Notice of AGM & Proxy Form 22 Oct 2025 12:25PM $0.028 $0.011 fallen by 60.71%
$13 US-veteran mental health trial patient recruitment complete 22 Oct 2025 8:30AM $0.027 $0.011 fallen by 59.26%
$13 Reinstatement to Official Quotation 16 Oct 2025 9:27AM $0.011 $0.011 fallen by 0%

26 - 50 of 210 results

Page 2 of 9

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.